Baidu
map

传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

2022 CDC临时指南：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核

2022-02-25 美国疾病控制与预防中心 MMWR Morb Mortal Wkly Rep

莫西沙星利福喷汀药物敏感性肺结核

2022年2月，美国疾病控制与预防中心(CDC)发布了：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核的临时指南。基于最新的研究结果，CDC建议将4个月利福喷汀-莫西沙星的治疗方案作为年龄≥1

中文标题：

2022 CDC临时指南：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核

英文标题：

Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022

发布机构：

美国疾病控制与预防中心

发布日期：

2022-02-25

简要介绍：

2022年2月，美国疾病控制与预防中心(CDC)发布了：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核的临时指南。基于最新的研究结果，CDC建议将4个月利福喷汀-莫西沙星的治疗方案作为年龄≥12岁药物敏感性肺结核患者的一种治疗方案并应用该治疗方案的注意事项。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 CDC临时指南：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6989a1c002a41027, title=2022 CDC临时指南：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核, enTitle=Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022, guiderFrom=MMWR Morb Mortal Wkly Rep, authorId=0, author=, summary=2022年2月，美国疾病控制与预防中心(CDC)发布了：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核的临时指南。基于最新的研究结果，CDC建议将4个月利福喷汀-莫西沙星的治疗方案作为年龄&ge;1, cover=https://img.medsci.cn/20220518/1652874205166_1608702.png, journalId=0, articlesId=null, associationId=109, associationName=美国疾病控制与预防中心, associationIntro=致力于保护健康和促进预防和控制疾病，设有疾病预防控制中心咨询委员会&mdash;&mdash;联邦咨询委员会，提供卫生监测系统的监测和防止疾病暴发（包括生物恐怖主义），实施疾病预防战略，并保持国家卫生统计与各国和其他合。提供流行病学统计等数据。, copyright=0, guiderPublishedTime=Fri Feb 25 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2022年2月，美国疾病控制与预防中心(CDC)发布了：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核的临时指南。基于最新的研究结果，CDC建议将4个月利福喷汀-莫西沙星的治疗方案作为年龄&ge;12岁药物敏感性肺结核患者的一种治疗方案并应用该治疗方案的注意事项。</span></p>, tagList=[TagDto(tagId=6282, tagName=莫西沙星), TagDto(tagId=22052, tagName=利福喷汀), TagDto(tagId=438103, tagName=药物敏感性肺结核)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4605, appHits=56, showAppHits=0, pcHits=641, showPcHits=4549, likes=0, shares=11, comments=3, approvalStatus=1, publishedTime=Thu May 19 15:35:00 CST 2022, publishedTimeString=2022-02-25, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Wed May 18 19:46:09 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Mon Jan 01 10:53:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 CDC临时指南：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核.pdf)])
2022 CDC临时指南：利福喷汀-莫西沙星4个月方案治疗药物敏感性肺结核.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1221123, encodeId=3348122112306, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Fri May 20 10:44:50 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221121, encodeId=704f122112139, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Fri May 20 10:40:38 CST 2022, time=2022-05-20, status=1, ipAttribution=)]
    2022-05-20 ms3000001005882169

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1221123, encodeId=3348122112306, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Fri May 20 10:44:50 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221121, encodeId=704f122112139, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Fri May 20 10:40:38 CST 2022, time=2022-05-20, status=1, ipAttribution=)]
    2022-05-20 ms3000001005882169

    学习了

    0

Baidu
map
Baidu
map
Baidu
map